Sumit Capital’s Idexx Laboratories IDXX Stock Holding History

Sumit Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,513	Closed	-$225K	–	26
2015 Q2	$225K	Buy	+3,513	New	+$243K	1.35%	35

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumit Capital's IDXX Position: Q3 2015 in Review

Sumit Capital sold out of Idexx Laboratories (IDXX) in Q3 2015, closing a stake of 3,513 shares — an estimated $225K sold.

Sumit Capital first reported a position in IDXX in Q2 2015 and held it in 1 quarter. The position peaked at $225K in Q2 2015. 356 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

Sumit Capital reported no remaining Idexx Laboratories position as of Q3 2015 after selling out during the quarter.
Sumit Capital sold 3,513 Idexx Laboratories shares in Q3 2015, an estimated $225K.
Sumit Capital first reported a position in Idexx Laboratories in Q2 2015 and held it in 1 quarter.
Sumit Capital's Idexx Laboratories position peaked at $225K in Q2 2015.
356 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on Sumit Capital's 13F filing for Q3 2015.